USANA Health Sciences, Inc. (USNA)

Over the past six months, USANA Health Sciences' stock price has decreased. Recent earnings reports have shown mixed results, with Q1 2026 EPS beating estimates but net earnings declining. USANA announced its fiscal year 2025 net sales were expected to be approximately $925 million and issued an initial 2026 sales outlook projecting revenue between $925 million and $1 billion. Insider trading activity in the past three months has shown more selling than buying.

The provided search results do not explicitly detail the demand seasonality for USANA Health Sciences' products and services. However, the company's business model, which is heavily dependent on direct selling, makes it susceptible to market fluctuations. Consumer trends indicate a prioritization of proactive health and wellness, driving demand for supplements that enhance energy, support women's health, aid in weight management, and improve mood.

USANA Health Sciences, Inc. is a multi-level marketing company based in Utah that develops, manufactures, and distributes science-based nutritional supplements, functional foods, and personal care products. It operates primarily through a direct selling model, with additional direct-to-consumer channels through its Hiya and Rise Wellness businesses. USANA's products are formulated in its own laboratories to meet pharmaceutical-grade standards and are categorized in the Medical sector.

USANA Health Sciences operates globally, serving markets in North America, Asia Pacific, Europe, and Latin America. Its products are sold in 24 countries, with plans to expand to India. Manufacturing facilities are located in Salt Lake City, Utah, and Tlalnepantla, Mexico.

USANA Health Sciences emphasizes its commitment to science-based products, quality, and a people-first culture. The company has received recognition for its workplace culture, earning a spot on the 2026 USA TODAY Top Workplaces award list. Its CellSentials supplement earned a ConsumerLab.com Seal of Approval in March 2026, and the company launched a new ingestible skincare supplement called "Glow" in April 2026.

USANA Health Sciences has a diverse ownership structure, with significant institutional and individual holdings. Institutional investors collectively held 57.88% of the company as of March 31, 2025. Founder Dr. Myron W. Wentz remains a significant individual shareholder, owning 109.96% of the company. Insiders collectively hold 0.82% of the stock.